1 completed, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Community Acquired Pneumonia, Severe: new trials by email Literature Review of Community Acquired Pneumonia, Severe trials Research Report on Community Acquired Pneumonia, Severe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE) RESPIRE score - Pneumonia, Pneumonia - Bacterial | Completed | Azienda Ospedaliero-Universitaria Careggi | 300 | 2022-01-01 | 2026-02-23 | |
| Ticagrelor in Severe Community Acquired Pneumonia Ticagrelor, Placebo - Community Acquired Pneumonia, Severe | Phase 2 | Terminated | Gordon Bernard | 25 | 2014-08-01 | 2017-12-11 |
Community-Acquired Pneumonia (2) · Pneumonia (2) · Emergencies (1) · Pneumonia, Bacterial (1)
Community-Acquired Infections (2) · Infections (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Ticagrelor (1)
Azienda Ospedaliero-Universitaria Careggi (1) · Gordon Bernard (1)
Italy (1) · United States (1)
Gordon R Bernard, MD (1) · Jon D Truwit, MD (1)